MONTECET
Montelukast Sodium is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT1 receptor.
Levocetirizine HCL, is an orally active H1-receptor antagonist.
ESSEL FORTE
ESSEL FORTE is a brown cap with red size#0 hard gelatin capsules. Phospholipids are major membrane constituents. The principal constituent of ESSEL FORTE is highly purified “essential” phospholipids, the EPL substance.
Label
Formulation and Dosage
Indication
Distribution
Label
CAPSULE
LIVER THERAPY
Formulation and Dosage
FORMULATION:
Each capsule contains:
Phospholipids………………………………………………………………….……300 mg
a-Tocopheryl acetate (Vitamin E)…………………………………..……..6 mg
Thiamine mononitrate (Vitamin B1)………………………………………6 mg
Riboflavin (Vitamin B2)………………………………………………………….6 mg
Nicotinamide (Vitamin B3)……………………………………………………30 mg
Pyridoxine HCI (Vitamin B6)………………………………………………….6 mg
Cyanocobalamin (Vitamin B12)…………………………………………….6 mcg
Indication
Acute and Chronic Hepatitis: Dystrophy and cirrhosis of the liver, biliary stasis and hepatic coma. Liver Damaged by Toxins: Fatty liver, prophylaxis of recurrent gallstones, radiation damage, nephrotic syndrome and gestosis.
Distribution
FDA Registration Number: DRP-5608
Manufacturer: Nabros Pharma Pvt. Ltd.
Product Categories
Share this Product:
Other Products
Q-CETYL
Acetylcysteine exerts an intensive mucolytic-fluidifying action on the mucous and mucopurulent secretions by depolymerizing the mucoprotein complexes and the nucleic acids which confer viscosity to the vitreous and purulent component of the sputum and other secretions.
Q-MEP
Omeprazole is used to treat excess stomach acid in conditions such as non cancerous stomach ulcers, gastroesophageal reflux disease (GERD), active duodenal ulcer, Zollinger-Ellison syndrome and erosive esophagitis. Omeprazole works by blocking gastric acid production and is from the group of medicines called proton pump inhibitors.
SALBUGEN PLUS
The combination of salbutamol with guaifenesin is designed to relieve respiratory obstruction and improve pulmonary ventilation. Respiratory disorders where bronchospasm and excessive secretion of tenacious mucus are complicating factors, e.g. bronchial asthma, chronic bronchitis and emphysema.